Mizuho Cuts Immunocore (IMCR) Price Target to $34 Amid Revenue Trim
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowMizuho Securities reduced Immunocore's (IMCR) stock price target to $34, reflecting a decrease in anticipated revenue. The analysts' revision indicates a potential impact on investor sentiment towards the company. This adjustment comes as market expectations may adjust in response to updated revenue forecasts. The reduction in price target identifies a cautionary stance regarding Immunocore's financial performance and future prospects.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
